Pravastatin Sodium
Brand name: Pravastatin Sodium
Rank #190 of 500 drugs by total cost
$76.8M
Total Cost
4,033,829
Total Claims
$76.8M
Total Cost
76,773
Prescribers
$19
Cost per Claim
938,434
Beneficiaries
10,183,604
30-Day Fills
$1,001
Avg Cost/Provider
53
Avg Claims/Provider
About Pravastatin Sodium
Pravastatin Sodium (sold as Pravastatin Sodium) was prescribed 4,033,829 times by 76,773 Medicare Part D providers in 2023, costing the program $76.8M. At $19 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 187 | Certolizumab Pegol (Cimzia) | $79.9M | 11,784 |
| 188 | Celecoxib (Celecoxib) | $77.7M | 1,938,505 |
| 189 | Sod Phenylbutyrat/Taurursodiol (Relyvrio) | $77.0M | 6,152 |
| 190 | Pravastatin Sodium (Pravastatin Sodium) | $76.8M | 4,033,829 |
| 191 | Lanadelumab-Flyo (Takhzyro) | $76.5M | 1,670 |
| 192 | Diltiazem Hcl (Diltiazem 24hr Er (Cd)) | $75.9M | 1,846,124 |
| 193 | Carvedilol (Carvedilol) | $75.6M | 6,390,691 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology